| 1 |
Bray F，Ferlay J，Soerjomataram I，et al．Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]．CA Cancer J Clin，2018，68（6）：394-424．
|
| 2 |
Sun S，Wang YH，Gao X，et al．Current perspectives and trends in nanoparticle drug delivery systems in breast cancer：bibliometric analysis and review[J]．Front Bioeng Biotechnol，2023，11：1253048．
|
| 3 |
Li N，Tan F，Chen W，et al．One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study[J]．Lancet Respir Med，2022，10（4）：378-391．
|
| 4 |
National Lung Screening Trial Research Team；Aberle DR，Adams AM，et al．Reduced lung-cancer mortality with low-dose computed tomographic screening[J]．N Engl J Med，2011，365（5）：395-409．
|
| 5 |
Becker N，Motsch E，Trotter A，et al．Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial[J]．Int J Cancer，2020，146（6）：1503-1513．
|
| 6 |
Pastorino U，Silva M，Sestini S，et al．Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy[J]．Ann Oncol，2019，30（7）：1162-1169．
|
| 7 |
Wang F，Tan F，Shen S，et al．Risk-stratified Approach for Never- and Ever-Smokers in Lung Cancer Screening: A Prospective Cohort Study in China[J]．Am J Respir Crit Care Med，2023，207（1）：77-88．
|
| 8 |
Zhao ZR，Situ DR，Lau RWH，et al．Comparison of Segmentectomy and Lobectomy in Stage IA Adenocarcinomas[J]．J Thorac Oncol，2017，12（5）：890-896．
|
| 9 |
Ost D，Goldberg J，Rolnitzky L，et al．Survival after surgery in stage IA and IB non-small cell lung cancer[J]．Am J Respir Crit Care Med，2008，177（5）：516-523．
|
| 10 |
Mazzone PJ，Lam L．Evaluating the Patient With a Pulmonary Nodule: A Review[J]．JAMA，2022，327（3）：264-273．
|
| 11 |
Gould MK，Tang T，Liu IL，et al．Recent Trends in the Identification of Incidental Pulmonary Nodules[J]．Am J Respir Crit Care Med，2015，192（10）：1208-1214．
|
| 12 |
de Koning HJ，van der Aalst CM，de Jong PA，et al．Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial[J]．N Engl J Med，2020，382（6）：503-513．
|
| 13 |
Lambin P，Rios-Velazquez E，Leijenaar R，et al．Radiomics: extracting more information from medical images using advanced feature analysis[J]．Eur J Cancer，2012，48（4）：441-446．
|
| 14 |
Kumar V，Gu Y，Basu S，et al．Radiomics: the process and the challenges[J]．Magn Reson Imaging，2012，30（9）：1234-1248．
|
| 15 |
Liu A，Wang Z，Yang Y，et al．Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram[J]．Cancer Commun (Lond)，2020，40（1）：16-24．
|
| 16 |
Jeong WK，Jamshidi N，Felker ER，et al．Radiomics and radiogenomics of primary liver cancers[J]．Clin Mol Hepatol，2019，25（1）：21-29．
|
| 17 |
Chen T，Wu J，Cui C，et al．CT-based radiomics nomograms for preoperative prediction of diffuse-type and signet ring cell gastric cancer: a multicenter development and validation cohort[J]．J Transl Med，2022，20（1）：38．
|
| 18 |
Miao S，Jia H，Cheng K，et al．Deep learning radiomics under multimodality explore association between muscle/fat and metastasis and survival in breast cancer patients[J]．Brief Bioinform，2022，23（6）:bbac432．
|
| 19 |
Zhang J，Jin J，Ai Y，et al．Differentiating the pathological subtypes of primary lung cancer for patients with brain metastases based on radiomics features from brain CT images[J]．Eur Radiol，2021，31（2）：1022-1028．
|
| 20 |
Mayerhoefer ME，Materka A，Langs G，et al．Introduction to Radiomics[J]．J Nucl Med，2020，61（4）：488-495．
|
| 21 |
McCague C，Ramlee S，Reinius M，et al．Introduction to radiomics for a clinical audience[J]．Clin Radiol，2023，78（2）：83-98．
|
| 22 |
Liu Z，Wang S，Dong D，et al．The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology：Opportunities and Challenges[J]．Theranostics，2019，9（5）：1303-1322．
|
| 23 |
Lohmann P，Bousabarah K，Hoevels M，et al．Radiomics in radiation oncology-basics，methods，and limitations[J]．Strahlenther Onkol，2020，196（10）：848-855．
|
| 24 |
Limkin EJ，Sun R，Dercle L，et al．Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology[J]．Ann Oncol，2017，28（6）：1191-1206．
|
| 25 |
Keek SA，Leijenaar RT，Jochems A，et al．A review on radiomics and the future of theranostics for patient selection in precision medicine[J]．Br J Radiol，2018，91（1091）：20170926．
|
| 26 |
Kuhnert G，Boellaard R，Sterzer S，et al．Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis[J]．Eur J Nucl Med Mol Imaging，2016，43（2）：249-258．
|
| 27 |
Yue WY，Zhang HT，Gao S，et al．Predicting Breast Cancer Subtypes Using Magnetic Resonance Imaging Based Radiomics With Automatic Segmentation[J]．J Comput Assist Tomogr，2023，47（5）：729-737．
|
| 28 |
Huang B，Lin X，Shen J，et al．Accurate and Feasible Deep Learning Based Semi-Automatic Segmentation in CT for Radiomics Analysis in Pancreatic Neuroendocrine Neoplasms[J]．IEEE J Biomed Health Inform，2021，25（9）：3498-3506．
|
| 29 |
Aerts HJ，Velazquez ER，Leijenaar RT，et al．Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach[J]．Nat Commun，2014，5：4006．
|
| 30 |
Xu H，Zhu N，Yue Y，et al．Spectral CT-based radiomics signature for distinguishing malignant pulmonary nodules from benign[J]．BMC Cancer，2023，23（1）：91．
|
| 31 |
Chen A，Lu L，Pu X，et al．CT-Based Radiomics Model for Predicting Brain Metastasis in Category T1 Lung Adenocarcinoma[J]．AJR Am J Roentgenol，2019，213（1）：134-139．
|
| 32 |
Zhao Q，Wang JW，Yang L，et al．CT diagnosis of pleural and stromal invasion in malignant subpleural pure ground-glass nodules：an exploratory study[J]．Eur Radiol，2019，29（1）：279-286．
|
| 33 |
Wu YL，Zhou Q．Combination Therapy for EGFR-Mutated Lung Cancer[J]．N Engl J Med，2023，389（21）：2005-2007．
|
| 34 |
Mattonen SA，Palma DA，Johnson C，et al．Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer：Physician Performance Versus Radiomic Assessment[J]．Int J Radiat Oncol Biol Phys，2016，94（5）：1121-1128．
|
| 35 |
Kammer MN，Lakhani DA，Balar AB，et al．Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules[J]．Am J Respir Crit Care Med，2021，204（11）：1306-1316．
|
| 36 |
Tanoue LT，Tanner NT，Gould MK，et al．Lung cancer screening[J]．Am J Respir Crit Care Med，2015，191（1）：19-33．
|
| 37 |
Ardila D，Kiraly AP，Bharadwaj S，et al．End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography[J]．Nat Med，2019，25（6）：954-961．
|
| 38 |
Rami-Porta R，Asamura H，Travis WD，et al．Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual[J]．CA Cancer J Clin，2017，67（2）：138-155．
|
| 39 |
Das SK，Fang KW，Xu L，et al．Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas[J]．Sci Rep，2021，11（1）：10829．
|
| 40 |
Cong M，Yao H，Liu H，et al．Development and evaluation of a venous computed tomography radiomics model to predict lymph node metastasis from non-small cell lung cancer[J]．Medicine (Baltimore)，2020，99（18）：e20074．
|
| 41 |
Zhang H，Liao M，Guo Q，et al．Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method[J]．Med Phys，2023，50（4）：2049-2060．
|
| 42 |
Chen L，Yu L，Li X，et al．Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC[J]．Contrast Media Mol Imaging，2022，2022：7642511．
|
| 43 |
Coroller TP，Grossmann P，Hou Y，et al．CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma[J]．Radiother Oncol，2015，114（3）：345-350．
|
| 44 |
E L，Lu L，Li L，et al．Radiomics for Classifying Histological Subtypes of Lung Cancer Based on Multiphasic Contrast-Enhanced Computed Tomography[J]．J Comput Assist Tomogr，2019，43（2）：300-306．
|
| 45 |
Eguchi T，Kondo R，Kawakami S，et al．Computed tomography attenuation predicts the growth of pure ground-glass nodules[J]．Lung Cancer，2014，84（3）：242-247．
|
| 46 |
Kodama K，Higashiyama M，Yokouchi H，et al．Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years[J]．Ann Thorac Surg，2002，73（2）：386-392．
|
| 47 |
Xiang W，Xing Y，Jiang S，et al．Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography[J]．Cancer Imaging，2014，14（1）：33．
|
| 48 |
Sun Y，Li C，Jin L，et al．Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction[J]．Eur Radiol，2020，30（7）：3650-3659．
|
| 49 |
Schneider JL，Lin JJ，Shaw AT．ALK-positive lung cancer：a moving target[J]．Nat Cancer，2023，4（3）：330-343．
|
| 50 |
Wang S，Yu H，Gan Y，et al．Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer：a multicohort study[J]．Lancet Digit Health，2022，4（5）：e309-e319．
|
| 51 |
Huynh E，Coroller TP，Narayan V，et al．CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer[J]．Radiother Oncol，2016，120（2）：258-266．
|
| 52 |
卢楚鸣，陈艾琪，曹胜男，等．基于3D-CT影像组学预测小细胞肺癌经铂类化疗后脑转移的研究[J]．临床放射学杂志，2023，42（3）：411-416．
|
| 53 |
Dercle L，Fronheiser M，Lu L，et al．Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics[J]．Clin Cancer Res，2020，26（9）：2151-2162．
|
| 54 |
Gould MK，Ananth L，Barnett PG，et al．A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules[J]．Chest，2007，131（2）：383-388．
|
| 55 |
张桐睿，李军，申敏，等．CT影像组学结合肺癌血清肿瘤标志物预测非小细胞肺癌亚型的初步研究[J]．中国CT和MRI杂志，2023，21（3）：65-67．
|
| 56 |
Balata H，Quaife SL，Craig C，et al．Early Diagnosis and Lung Cancer Screening[J]．Clin Oncol (R Coll Radiol)，2022，34（11）：708-715．
|
| 57 |
Kim MG，Yang BR，Park CM，et al．Preoperative percutaneous needle lung biopsy techniques and ipsilateral pleural recurrence in stage I lung cancer[J]．Eur Radiol，2022，32（4）：2683-2692．
|
| 58 |
Kim YW，Kang HR，Kwon BS，et al．Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers[J]．Eur Respir J，2020，56（5）：2000177．
|
| 59 |
Wang Q，Sheng Y，Jiang Z，et al．What Imaging Modality Is More Effective in Predicting Early Recurrence of Hepatocellular Carcinoma after Hepatectomy Using Radiomics Analysis：CT or MRI or Both[J]．Diagnostics（Basel），2023，13（12）：2012．
|
| 60 |
Beer L，Sahin H，Bateman NW，et al．Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis[J]．Eur Radiol，2020，30（8）：4306-4316．
|
| 61 |
Xu X，Zhang HL，Liu QP，et al．Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma[J]．J Hepatol，2019，70（6）：1133-1144．
|
| 62 |
Hu Y，Xie C，Yang H，et al．Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma[J]．JAMA Netw Open，2020，3（9）：e2015927．
|
| 63 |
Agosti A，Shaqiri E，Paoletti M，et al．Deep learning for automatic segmentation of thigh and leg muscles[J]．MAGMA，2022，35（3）：467-483．
|
| 64 |
Oreiller V，Andrearczyk V，Jreige M，et al．Head and neck tumor segmentation in PET/CT：The HECKTOR challenge[J]．Med Image Anal，2022，77：102336．
|
| 65 |
Zwanenburg A，Vallières M，Abdalah MA，et al．The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping[J]．Radiology，2020，295（2）：328-338．
|
| 66 |
Hagiwara A，Fujita S，Ohno Y，et al．Variability and Standardization of Quantitative Imaging: Monoparametric to Multiparametric Quantification, Radiomics, and Artificial Intelligence[J]．Invest Radiol，2020，55（9）：601-616．
|
| 67 |
Visvikis D，Lambin P，Beuschau Mauridsen K，et al．Application of artificial intelligence in nuclear medicine and molecular imaging: a review of current status and future perspectives for clinical translation[J]．Eur J Nucl Med Mol Imaging，2022，49（13）：4452-4463．
|
| 68 |
Rompianesi G，Pegoraro F，Ceresa CD，et al．Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases[J]．World J Gastroenterol，2022，28（1）：108-122．
|